{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:04:44Z","timestamp":1781863484547,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 HL 150280"],"award-info":[{"award-number":["K23 HL 150280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007891"],"award-info":[{"award-number":["T32 HL007891"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.transproceed.2024.11.016","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T13:07:59Z","timestamp":1733576879000},"page":"342-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Lung Transplant Recipients: A Single Center Report"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7756-9375","authenticated-orcid":false,"given":"Claire E.","family":"Fishman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Walshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Claridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Witek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-7643","authenticated-orcid":false,"given":"Michaela R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.transproceed.2024.11.016_bib0001","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics","volume":"40","author":"Chambers","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.transproceed.2024.11.016_bib0002","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2024.11.016_bib0003","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival-Making progress when most needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2024.11.016_bib0004","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajt.16978","article-title":"OPTN\/SRTR 2020 Annual Data Report: Liver","volume":"22","author":"Kwong","year":"2022","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.transproceed.2024.11.016_bib0005","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/TP.0000000000004222","article-title":"New-onset Obesity After Lung Transplantation: Incidence, Risk Factors, and Clinical Outcomes","volume":"106","author":"Jomphe","year":"2022","journal-title":"Transplantation"},{"issue":"14","key":"10.1016\/j.transproceed.2024.11.016_bib0006","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.3390\/jcm11144127","article-title":"Diabetes Is an Independent Risk Factor for Cancer after Heart and\/or Lung Transplantation","volume":"11","author":"Kirov","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.transproceed.2024.11.016_bib0007","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ejcts.2008.01.050","article-title":"Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors","volume":"33","author":"Ollech","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"10.1016\/j.transproceed.2024.11.016_bib0008","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.healun.2019.08.013","article-title":"Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study","volume":"38","author":"Anderson","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2024.11.016_bib0009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/tri.12721","article-title":"Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis","volume":"29","author":"Upala","year":"2016","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.transproceed.2024.11.016_bib0010","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.201104-0728OC","article-title":"Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study","volume":"184","author":"Lederer","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.transproceed.2024.11.016_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2023.100028","article-title":"Provider beliefs and practices regarding the management of obesity in lung transplant recipients","volume":"3","author":"Diamond","year":"2024","journal-title":"JHLT Open"},{"issue":"10278","key":"10.1016\/j.transproceed.2024.11.016_bib0012","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.transproceed.2024.11.016_bib0013","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.transproceed.2024.11.016_bib0014","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.transproceed.2024.11.016_bib0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/obr.12839","article-title":"Semaglutide as a promising antiobesity drug","volume":"20","author":"Christou","year":"2019","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.transproceed.2024.11.016_bib0016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","article-title":"Semaglutide for the treatment of obesity","volume":"33","author":"Chao","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.transproceed.2024.11.016_bib0017","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/tri.13883","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation","volume":"34","author":"Ertuglu","year":"2021","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.transproceed.2024.11.016_bib0018","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5500\/wjt.v7.i2.103","article-title":"Role of gastroesophageal reflux disease in lung transplantation","volume":"7","author":"Hathorn","year":"2017","journal-title":"World J Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2024.11.016_bib0019","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1034\/j.1399-0012.2003.00060.x","article-title":"Gastroesophageal reflux disease in lung transplant recipients","volume":"17","author":"Hadjiliadis","year":"2003","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2024.11.016_bib0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ALN.0000000000004776","article-title":"ASA Consensus-based Guidance on Preoperative Management of Patients on Glucagon-like Peptide-1 Receptor Agonists","volume":"140","author":"Ushakumari","year":"2024","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.transproceed.2024.11.016_bib0021","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/15269248221122867","article-title":"Single-center Evaluation of Safety & Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Solid Organ Transplantation","volume":"32","author":"Sweiss","year":"2022","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2024.11.016_bib0022","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007890-201407151-01757","article-title":"Long-Acting Glucagon-Like Peptide-1 (GLP-1) Agonist Therapy in Post Solid Organ Transplant Patients.: Abstract# B913","volume":"98","author":"Krisl","year":"2014","journal-title":"Transplantation"},{"issue":"Supplement_1","key":"10.1016\/j.transproceed.2024.11.016_bib0023","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/ofid\/ofab466.821","article-title":"623. Exploring \u2018slicer dicer\u2019, an extraction tool in EPIC, for clinical and epidemiological analysis","volume":"8","author":"Saini","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.transproceed.2024.11.016_bib0024","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s13300-020-00786-1","article-title":"A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation","volume":"11","author":"Thangavelu","year":"2020","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.transproceed.2024.11.016_bib0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/14017431.2020.1726444","article-title":"Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience","volume":"54","author":"Nyk\u00e4nen","year":"2020","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"10.1016\/j.transproceed.2024.11.016_bib0026","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2021200314","article-title":"Chronic Lung Allograft Dysfunction: Review of CT and Pathologic Findings","volume":"3","author":"Byrne","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"10148","key":"10.1016\/j.transproceed.2024.11.016_bib0027","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.transproceed.2024.11.016_bib0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.transproceed.2024.11.016_bib0029","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s12325-022-02153-x","article-title":"Efficacy of GLP-1RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review","volume":"39","author":"Jensterle","year":"2022","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.transproceed.2024.11.016_bib0030","doi-asserted-by":"crossref","first-page":"e1385","DOI":"10.1097\/TXD.0000000000001385","article-title":"Relationship of Exercise Capacity, Physical Function, and Frailty Measures With Clinical Outcomes and Healthcare Utilization in Lung Transplantation: A Scoping Review","volume":"8","author":"Bourgeois","year":"2022","journal-title":"Transplant Direct"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452400561X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452400561X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T17:47:17Z","timestamp":1740505637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452400561X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S004113452400561X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.11.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Lung Transplant Recipients: A Single Center Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}